CRIZOTINIB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,949 adverse event reports in the FDA FAERS database where CRIZOTINIB was used for Lung neoplasm malignant.
Most Reported Side Effects for CRIZOTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,028 | 20.4% | 2,025 | 116 |
| Neoplasm progression | 1,161 | 11.7% | 350 | 222 |
| Nausea | 820 | 8.2% | 90 | 244 |
| Disease progression | 677 | 6.8% | 285 | 146 |
| Diarrhoea | 631 | 6.3% | 63 | 181 |
| Vomiting | 600 | 6.0% | 98 | 216 |
| Fatigue | 419 | 4.2% | 39 | 94 |
| Off label use | 353 | 3.6% | 107 | 76 |
| Dyspnoea | 352 | 3.5% | 110 | 180 |
| Visual impairment | 315 | 3.2% | 29 | 44 |
| Constipation | 313 | 3.2% | 42 | 99 |
| Decreased appetite | 304 | 3.1% | 48 | 114 |
| Oedema peripheral | 303 | 3.1% | 36 | 93 |
| Asthenia | 281 | 2.8% | 64 | 125 |
| Peripheral swelling | 278 | 2.8% | 30 | 67 |
Other Indications for CRIZOTINIB
Non-small cell lung cancer (1,724)
Lung adenocarcinoma (548)
Non-small cell lung cancer metastatic (429)
Neoplasm malignant (365)
Lung cancer metastatic (256)
Product used for unknown indication (167)
Lung adenocarcinoma stage iv (164)
Non-small cell lung cancer stage iv (151)
Anaplastic large cell lymphoma t- and null-cell types (139)
Lung carcinoma cell type unspecified stage iv (128)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)
ATEZOLIZUMAB (1,262)